Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Treatment with Combination of Dabrafenib and Trametinib in Patients with Recurrent/Refractory BRAF V600E-Mutated Hairy Cell Leukemia (HCL)

Robert J. Kreitman, MD, Philippe Moreau, Martin Hutchings, MD, Anas Gazzah, MD, Jean-Yves Blay, MD PhD, Zev A. Wainberg, MD, Alexander Stein, MD, Sascha Dietrich, MD, Maja J.A. de Jonge, MD, Wolfgang Willenbacher, MD, Jacques De Greve, MD, Evgeny Arons, PhD, Farhad Ravandi, MD, Fatima Rangwala, Paul Burgess, Bijoyesh Mookerjee, Vivek Subbiah, MD

Blood (2018) 132 (Supplement 1): 391.

https://doi.org/10.1182/blood-2018-99-113135

Published: 2018

Journal Articles

The Addition Of Bortezomib (Velcade®) To The Combination Of Mitoxantrone and Etoposide For Relapsed Or Refractory Acute Leukemia Does Not Appear To Improve The Likelihood Of Response: Results Of a Phase II Trial

Neil D. Palmisiano, MD, Sameh Gaballa, MD, Bijoyesh Mookerjee, MD, John L. Wagner, MD, Margaret Kasner, MD, Matthew Carabasi, MD, Onder Alpdogan, MD, Ubaldo Martinez, MD, Mark Weiss, MD, Neal Flomenberg, MD, Joanne Filicko-O'Hara, MD

Blood (2013) 122 (21): 2689.

https://doi.org/10.1182/blood.V122.21.2689.2689

Published: 2013

Journal Articles

An Open-Label, Phase II Study Of The JAK1 Inhibitor INCB039110 In Patients With Myelofibrosis

John Mascarenhas, MD, Moshe Talpaz, MD, Vikas Gupta, MD, FRCP, FRCPath, Michael Savona, MD, FACP, Paul Coughlin, FRACP, PhD, Elliott Winton, MD, Deborah Hunter, PhD, Bijoyesh Mookerjee, MD, FACP, Lance Leopold, MD, Jason Clark, PhD, Peter O'Neill, MBA, CCRP, Ronald Hoffman, MD, Srdan Verstovsek, MD, PhD

Blood (2013) 122 (21): 663.

https://doi.org/10.1182/blood.V122.21.663.663

Published: 2013

Journal Articles

Long-Term Efficacy and Safety Results From a Phase II Study of Ruxolitinib in Patients with Polycythemia Vera

Srdan Verstovsek, MD, PhD, Francesco Passamonti, MD, Alessandro Rambaldi, MD, Giovanni Barosi, MD, Peter J. Rosen, MD, Shui He, PhD, Nancy Contel, DVM, Bijoyesh Mookerjee, MD, FACP, Elisa Rumi, MD, Elisabetta Gattoni, MD, Lisa Pieri, MD, Mario Cazzola, MD, Hagop M. Kantarjian, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD

Blood (2012) 120 (21): 804.

https://doi.org/10.1182/blood.V120.21.804.804

Published: 2012

Journal Articles

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing

Dolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, Margaret Kasner, John L. Wagner, Beth Colombe, Patricia Cornett Farley, William O'Hara, Phyllis Flomenberg, Maria Werner-Wasik, Janet Brunner, Bijoyesh Mookerjee, Terry Hyslop, Mark Weiss, Neal Flomenberg

Blood (2011) 118 (17): 4732–4739.

https://doi.org/10.1182/blood-2011-07-365338

Published: 2011

Journal Articles

Phase II Study of Bortezomib, Mitoxantrone and Etoposide In Relapsed/ Refractory Acute Leukemias

Joanne Filicko-O'Hara, MD, Bijoyesh Mookerjee, MBBS, Onder Alpdogan, MD, Emmanuel C. Besa, MD, Matthew Carabasi, MD, Elena Gitelson, MD, Margaret Kasner, MD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2010) 116 (21): 2192.

https://doi.org/10.1182/blood.V116.21.2192.2192

Published: 2010

Journal Articles

A Two Step Myeloablative Approach to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematological Malignancies From HLA Partially-Matched (Haploidentical) Related Donors.

Dolores Grosso, DNP, Matthew Carabasi, MD, Janet Brunner, PA-C, Beth Colombe, PhD, Joanne Filicko-O'Hara, MD, Eileen C Finnegan, CRNP, Phyllis Flomenberg, MD, Margaret Kasner, MD, Bijoyesh Mookerjee, MD, William O'Hara PharmD, Nyree Tedesco-Garafano, CRNP, John L. Wagner, MD, Maria Werner-Wasik, MD, Neal Flomenberg, MD, FACP

Blood (2009) 114 (22): 2292.

https://doi.org/10.1182/blood.V114.22.2292.2292

Published: 2009

Journal Articles

A Two Step Approach to Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Patients with Hematologic Disorders.

Neal Flomenberg, MD, Dolores Grosso, CRNP, Janet Brunner, PA-C, Matthew Carabasi, MD, Scott Dessain, MD, Joanne Filicko-OHara, MD, Bijoyesh Mookerjee, MD, Nyree Tedesco, CRNP, John L. Wagner, MD, Maria Werner-Wasik, MD

Blood (2007) 110 (11): 5072.

https://doi.org/10.1182/blood.V110.11.5072.5072

Published: 2007

Journal Articles

The Use of TCR Vβ Spectratype Analysis in Allogeneic Blood and Marrow Transplantation.

Thea M. Friedman, Deborah D. Hopely, Joshua L. Stern, Joanne Filicko, Bijoyesh Mookerjee, Delores Grosso, Neal Flomenberg, Robert Korngold

Blood (2004) 104 (11): 3072.

https://doi.org/10.1182/blood.V104.11.3072.3072

Published: 2004

NARROW

Treatment with Combination of Dabrafenib and Trametinib in Patients with Recurrent/Refractory BRAF V600E-Mutated Hairy Cell Leukemia (HCL)

The Addition Of Bortezomib (Velcade®) To The Combination Of Mitoxantrone and Etoposide For Relapsed Or Refractory Acute Leukemia Does Not Appear To Improve The Likelihood Of Response: Results Of a Phase II Trial

An Open-Label, Phase II Study Of The JAK1 Inhibitor INCB039110 In Patients With Myelofibrosis

Long-Term Efficacy and Safety Results From a Phase II Study of Ruxolitinib in Patients with Polycythemia Vera

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing

Phase II Study of Bortezomib, Mitoxantrone and Etoposide In Relapsed/ Refractory Acute Leukemias

A Two Step Myeloablative Approach to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematological Malignancies From HLA Partially-Matched (Haploidentical) Related Donors.

A Two Step Approach to Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Patients with Hematologic Disorders.

The Use of TCR Vβ Spectratype Analysis in Allogeneic Blood and Marrow Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only